21 results
8-K
EX-99.1
2kv2d1638oqj3
5 May 20
Regulation FD Disclosure
12:00pm
DEF 14A
42eqr5b
24 Apr 20
Definitive proxy
4:15pm
8-K
EX-99.1
bded87
20 Mar 20
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access
2:13pm
10-K
assqpx03g
26 Feb 20
Annual report
4:53pm
424B4
lunfbp
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
xe925yyuua7sa5g6ozkl
9 Jan 20
Draft registration statement
12:00am
8-K
EX-99.1
ov4dvlvl51rh
7 Aug 19
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattleās Growing Biotech Hub
5:29pm
424B4
2v3taywm
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
b70d7ynilbl3j2moqq
30 May 19
IPO registration
5:20pm
DRS/A
mce34y7b
8 May 19
Draft registration statement (amended)
12:00am